Compression device
AssigneeNational University of Ireland, Galway
InventorsAaron HANNON, Bárbara OLIVEIRA, Martin O'HALLORAN
Life of this patent
Estimating the term…
Abstract
A medical device comprising a bladder (or plurality of bladders), an attachment mechanism, a fluid inlet, a fluid outlet, a compressor, a pressure regulator system, and a perfusion sensor, which is compressed against intact tissue (unbroken skin or surface tissue in a cavity) for the purpose of minimising blood perfusion to prevent drug delivery to a non-target site.
Claims45
A pneumatic compression device (1,100) for use in preventing or treating chemotherapy-induced alopecia or chemotherapy-induced peripheral neuropathy (CIPN) in a subject receiving chemotherapy treatment, the device (1,100) comprising:
- an attachment member (2), a first layer (3) connected to the attachment member (2), at least one primary bladder (5);
- and a fluid inlet (12), wherein the at least one primary bladder (5) is configured to inflate with a fluid at ambient temperature, and which exerts a compressive pressure to the non-treated area of the subject when the bladder (5) is inflated minimising blood perfusion to prevent chemotherapy delivery to the non-treated area.
The pneumatic compression device of any one of the preceding claims, further comprising a secondary bladder (11), wherein the secondary bladder (11) is configured to attach to the attachment member (2) such that the secondary bladder (11) comes in contact with the tissue of the subject.
The pneumatic compression device (1) of any one of the preceding claims, further comprising a first fastening system (16) configured to prevent the outward movement of the outer mesh layer (6).
The pneumatic compression device (1) of any one of the preceding claims, further comprising at least one adjustable strap (10) to secure the device (1) under, around or over the chin of the subject.
The pneumatic compression device (1,100) of any one of the preceding claims, wherein the attachment member (2), the first fastening system (16), second fastening system (17), the first securing member (102), or the second securing member (103) can be used with greater force to tighten the device (1,100) against the surface of the scalp, foot, or hand through a drawstring mechanism.
A pneumatic compression device (200) for use in preventing or treating chemotherapy-induced infertility in a subject receiving chemotherapy treatment, the device (200) comprising:
- at least one primary bladder (205), an applicator (202) adapted to accommodate the at least one primary bladder (205), and a cap (204) configured to contain the at least one primary bladder (205) within the applicator (202) when deflated, wherein the at least one primary bladder (205) located within the applicator (202) is configured to inflate with air or a gas at ambient temperature, and which exerts a compressive pressure when the bladder (205) is inflated.
The pneumatic compression device (1,100,200) of the preceding claims, further comprising a control element (9).
The pneumatic compression (1,100,200) device of any one of the preceding claims, wherein the at least one primary bladder (5,205) further comprises a plurality of bladder compartments, each bladder compartment operating independently of each other.
The pneumatic compression device (1,100,200) of any one of the preceding claims, wherein when activated, the device (1,100,200) applies a compressive pressure of between about 20 mmHg to about 100 mmHg to the subject.
The pneumatic compression device (1,100,200) of any one of the preceding claims, wherein the compressive pressure is applied incrementally.
The pneumatic compression device (1,100,200) of any one of the preceding claims, further comprising a foam layer inserted within the at least one primary bladder (5,205) or one or more of the plurality of bladders;
- wherein the foam layer exerts a reaction force through the bladder onto the scalp, foot, hand, or within a cavity when air is withdrawn incrementally creating a vacuum inside the at least one primary bladder (5,205) or one or more of the plurality of bladders.
The pneumatic compression device (1,100) according to any one of the preceding claims, wherein a fluid or a solid which is viscous at ambient pressure and a solid form at pressures lower than atmospheric pressure, is inserted into the at least one primary bladder (5) or one or more of the plurality of bladders, wherein when pressure within the at least one primary bladder (5) decreases, the fluid or the sold hardens, creating a modifiable compressive force against the tissue.
The pneumatic compression device (1,100,200) of any one of the preceding claims, wherein the at least one primary bladder (5,205) or the plurality of bladders, are inflated are to a pre-determined pressure level below the target therapeutic pressure level prior to the user using the device (1,100,200).
The pneumatic compression device (1,100,200) of any one of the preceding claims, wherein the at least one primary bladder (5,205) or the plurality of bladders are provided at a pre-determined pressure level and are not further inflated.
The pneumatic compression device (1,100,200) of any one of the preceding claims, wherein the attachment member (2) further comprises at least one status indicator light (13).
A method of controlling drug delivery via the blood vessels to a target site on the body, the method comprising:
- mechanically compressing the skin/surface tissue at a target tissue site at a predetermined compressive force to occlude the upstream blood vessels;
- maintaining the compressive force for a predetermined period;
- and
- releasing the compressive force applied to the tissue at the target site at a pre-determined rate and in a pre-determined geometric pattern.
A method of controlling drug delivery to a target site on the body, followed by a period of reactivating blood flow to ensure long-term tissue viability, the method, comprising:
- mechanically compressing the skin/surface tissue at the target site with a predetermined compressive force to cause occlusion of the local microvasculature;
- maintaining microvasculature occlusion for a predetermined period of time such that drugs circulating through the vascular system do not reach the target site or site downstream of the target site;
- releasing the occlusion in a controlled manner at a pre-determined rate and in a pre-determined geometric pattern;
- sensing a physiological parameter;
- adjusting the mechanical compression applied to the tissue site based on the sensed physiological parameter;
- and
- applying compressive forces in a pulsatile fashion against the skin tissue to promote blood flow allowing waste agents to be removed from the local vasculature.
Dependencies are inferred from the claim text.